Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitreous Retina Macula Consultants of New York
New York, New York, United States
- Ownership
- Private
- Employees
- ~60
- Development stage
- Other
01
Overview
Vitreous Retina Macula Consultants of New York (VRMNY) is the largest retina center in the New York Metropolitan area, recognized internationally for clinical care, surgical expertise, academic research output, and participation in clinical trials, including gene therapy studies in wet age-related macular degeneration[1][4][5][7].
- Therapeutic areas
- Ophthalmology
- Modalities
- Non-pharmacological therapyDeviceGene therapy
- Industry
- Academic Hospital/University/Research
02
Partnerships
Regenxbio
Beyond the preview
Go deeper on Vitreous Retina Macula Consultants of New York.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitreous Retina Macula Consultants of New York.